University of Zurich

Date of Award



Type 1 Diabetes, Prevent & Delay



Term of Grant

24 months

Project Title

Generation of a bispecific interleukin-2 immunotherapy for preferential and pancreas-targeted stimulation of regulatory T cells in the treatment of type-1 diabetes mellitus

Project Description

Funds support activities into designing and preclinically testing a targeted immunotherapy for type 1 diabetes (T1D).